Australia - English - Department of Health (Therapeutic Goods Administration)

reach pharmaceuticals pty ltd - thiotepa, quantity: 15 mg - injection, powder for - excipient ingredients: - thiotepa-reach is indicated, in combination with other chemotherapy medicinal products: ? with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients; ? when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. (refer to section 5.2 clinical trials)

Singapore - English - HSA (Health Sciences Authority)

axxessbio pte. ltd. - thiotepa - injection, powder, lyophilized, for solution - thiotepa 100mg/vial

Singapore - English - HSA (Health Sciences Authority)

axxessbio pte. ltd. - thiotepa - injection, powder, lyophilized, for solution - thiotepa 15mg/vial

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - thiotepa - powder for concentrate for solution for infusion - thiotepa

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - thiotepa - powder for concentrate for solution for infusion - thiotepa